EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

84 hedge funds and large institutions have $236M invested in EyePoint Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 8 closing their positions.

Holders
84
Holders Change
+2
Holders Change %
+2.44%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
29
Reduced
26
Closed
8
Calls
$1.35M
Puts
$157K
Net Calls
+$1.19M
Net Calls Change
-$1.95M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$2.7M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$9.6M
3
Franklin Resources
3
Franklin Resources
California
$42.9M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.7M
5
Verition Fund Management
5
Verition Fund Management
Connecticut
$4.23M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$7.79M
2
Citadel Advisors
2
Citadel Advisors
Florida
$8.19M
3
Invesco
3
Invesco
Georgia
$0
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$881K
5
IC
5
Ikarian Capital
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WTA
76
Washington Trust Advisors
Massachusetts
$2K – – –
O
77
OrbiMed
New York
$1.69K +$1.69K +214,100 New
Daiwa Securities Group
78
Daiwa Securities Group
Japan
$1K – – –
CAPTRUST Financial Advisors
79
CAPTRUST Financial Advisors
North Carolina
$1K – – –
Invesco
80
Invesco
Georgia
– -$1.59M -130,999 Closed
IC
81
Ikarian Capital
Texas
– -$274K -22,552 Closed
Jane Street
82
Jane Street
New York
– -$169K -13,881 Closed
Allspring Global Investments
83
Allspring Global Investments
North Carolina
– -$62K -5,176 Closed
CG
84
Cutler Group
California
– -$41K -3,383 Closed
BAM
85
Bellevue Asset Management
Washington
– -$1K -84 Closed
1 2 3
4